Editorials and Opinions

Evolution of the COVID-19 vaccine development landscape.

Drug pricing in America is complex.

Modèles de Prix Pour Médicaments.

The End of the International Reference Pricing System?

Overall, many U.S. hospitals continue to face significant financial pressure from the pandemic as new infections remain high across much of the country.

Why companies can’t afford to create life-saving drugs.

Minimum Costs to Manufacture New Treatments for COVID-19.

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018

Price difference to foreign countries for patented drugs continues to decrease.

The most expensive drugs sold in American pharmacies can cost as much as a luxury car — every month.

Drugmakers actually sell their products for about half off list price.

Financialized Corporations in a National Innovation System: The US Pharmaceutical Industry

The pricing of Sovaldi (sofosbuvir).

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

Governments worldwide have made significant contributions to incentivize the discovery of medicines, both financially and non-financially.